6-116617083-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001010892.3(RSPH4A):c.460C>T(p.Gln154*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,461,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001010892.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 11Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RSPH4A | ENST00000229554.10 | c.460C>T | p.Gln154* | stop_gained | Exon 1 of 6 | 1 | NM_001010892.3 | ENSP00000229554.5 | ||
| RSPH4A | ENST00000368581.8 | c.460C>T | p.Gln154* | stop_gained | Exon 1 of 5 | 1 | ENSP00000357570.4 | |||
| RSPH4A | ENST00000368580.4 | c.460C>T | p.Gln154* | stop_gained | Exon 1 of 5 | 5 | ENSP00000357569.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251358 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 11 Pathogenic:1Other:1
- -
- -
Primary ciliary dyskinesia Pathogenic:1
This variant is present in population databases (rs118204041, ExAC 0.01%). This variant has been observed to be homozygous in individuals affected with primary ciliary dyskinesia (PMID: 19200523). In all cases, it has been reported in cis with a second variant in RSPH4A, c.259C>T (p.Pro87Ser), although the clinical significance of this variant is unknown. ClinVar contains an entry for this variant (Variation ID: 503). Loss-of-function variants in RSPH4A are known to be pathogenic (PMID: 19200523). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Gln154*) in the RSPH4A gene. It is expected to result in an absent or disrupted protein product. -
Respiratory ciliopathies including non-CF bronchiectasis Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at